Showing results (71-80 of 118) with videos related to
Sort By:
Pageof 12
Frontiers in Immunology|July 24, 2018
The Circadian Clock Drives Mast Cell Functions in Allergic ReactionsPia Christ, Anna Sergeevna Sowa, Oren Froy, et al.Behavioural Brain Research|October 16, 2015
Serotonin suppresses food anticipatory activity and synchronizes the food-entrainable oscillator during time-restricted feedingSigal Rozenblit-Susan, Nava Chapnik, Yoni Genzer, et al.Clinical Immunology (Orlando, Fla.)|July 28, 2009
A tolerogenic peptide that induces suppressor of cytokine signaling (SOCS)-1 restores the aberrant control of IFN-gamma signaling in lupus-affected (NZB x NZW)F1 miceAmir Sharabi, Zev M Sthoeger, Keren Mahlab, et al.The International Journal of Biochemistry & Cell Biology|June 1, 2016
Differential effect of fructose on fat metabolism and clock gene expression in hepatocytes vs. myotubesNava Chapnik, Sigal Rozenblit-Susan, Yoni Genzer, et al.Nutrients|July 15, 2026
Changes in Anthropometric and Biochemical Parameters Following High-Protein and High-Density Enteral Nutrition in Chronically Ventilated Patients: A Retrospective StudyJenny Nahman Sichin, Lena Valetzky, Yosef Mishal, et al.Journal of Autoimmunity|August 25, 2009
High circulating levels of free interleukin-18 in patients with active SLE in the presence of elevated levels of interleukin-18 binding proteinDaniela Novick, Daniel Elbirt, Galit Miller, et al.The Israel Medical Association Journal : IMAJ|September 24, 2015
Granulomatous Lobular MastitisKeren Mahlab-Guri, Ilan Asher, Tanir Allweis, et al.Experimental Gerontology|March 8, 2011
Long-lived mice exhibit 24 h locomotor circadian rhythms at young and old ageRoee Gutman, Yoni Genzer, Nava Chapnik, et al.Human Immunology|March 13, 2009
The tolerogenic peptide hCDR1 downregulates pathogenic cytokines and apoptosis and upregulates immunosuppressive molecules and regulatory T cells in peripheral blood mononuclear cells of lupus patientsZev M Sthoeger, Amir Sharabi, Molly Dayan, et al.Journal of Autoimmunity|April 7, 2009
Treatment of lupus patients with a tolerogenic peptide, hCDR1 (Edratide): immunomodulation of gene expressionZev M Sthoeger, Amir Sharabi, Yair Molad, et al.Pageof 12